Back

Evaluating C-reactive protein-to-lymphocyte ratio: is there room for another biomarker in infective endocarditis?

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in valvular heart disease - epidemiology, prognosis, outcome Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Mariana Rodrigues Simoes

Coimbra Hospital and University Center, Coimbra (Portugal)

7 More presentations in this session

Presentation thumbnail
The role of novel biomarkers of systemic inflammation in the hospitalisation of patients with aortic stenosis
Doctor L. Brochado (Almada, PT)
Abstract Slides Video
Presentation thumbnail
Heart failure in patients with staphylococcus aureus-associated infective endocarditis
Doctor I. Meray (Tyre, LB)
Abstract Slides Video
Presentation thumbnail
Sex-differences and long-term outcomes after aortic valve replacement
Doctor A. Fonseca Vazao (Leiria, PT)
Abstract Slides Video
Presentation thumbnail
Clinical and echocardiographic predictors of long-term adverse outcomes after aortic valve replacement
Doctor A. Fonseca Vazao (Leiria, PT)
Abstract Slides Video
Presentation thumbnail
Characterisation of pre-intervention outcomes in very old patients with severe aortic stenosis
Doctor A. Fonseca Vazao (Leiria, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in valvular heart disease - epidemiology, prognosis, outcome

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
The prognostic relevance of neutrophil-to-lymphocyte ratio in infective endocarditis for heart failure patients
thumbnail
Congress Presentation
The value of calculated inflammation indices for assessing the risk of hospital mortality in infective endocarditis
thumbnail
Congress Presentation
Neutrophil count and neutrophil to lymphocyte ratio: possible markers for post-transcatheter aortic valve replacement complications?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources